<DOC>
	<DOCNO>NCT01535417</DOCNO>
	<brief_summary>The purpose study evaluate efficacy safety 'Shinbaro Capsule ' , new herbal anti-arthritic agent , patient osteoarthritis knee .</brief_summary>
	<brief_title>Efficacy Safety Shinbaro Capsule</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Celecoxib</mesh_term>
	<criteria>age 35 80 diagnosed Knee OA base criterion ACR show ont I ~ III Kellgren Stage radiography wuffered constantly Knee OA 6 month prior begin study score 30 total WOMAC scale comorbid orthopedic disease OA index knee significant trauma surgery</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>February 2012</verification_date>
	<keyword>Osteoarthritis</keyword>
</DOC>